BAGDIG BAGHDASSARIAN, MD
Internal Medicine Physician in GREAT NECK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
BAGDIG BAGHDASSARIAN, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 11,865 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 12K
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
BAGDIG BAGHDASSARIAN, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
BAGDIG BAGHDASSARIAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about BAGDIG BAGHDASSARIAN, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Internal Medicine Physician compares to other specialties among New York providers
Internal Medicine Physician share within New York
Internal Medicine Physician is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
BAGDIG BAGHDASSARIAN, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Internal Medicine Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Internal Medicine Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BAGDIG BAGHDASSARIAN, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 15 ARLEIGH RD, GREAT NECK, NY, 11021, with a listed phone of (516) 566-1139. NPI 1942253158 was issued on 05/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAGHDASSARIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 11,865 prescription claims written by this provider, covering 485 Medicare beneficiaries and totaling roughly $850K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 5.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942253158 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BAGDIG BAGHDASSARIAN, MD's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to BAGDIG BAGHDASSARIAN, MD. To verify BAGDIG BAGHDASSARIAN, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 11,865 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 11,918
- Total Day Supply
- 266,434
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $586K
- Generic Drug Cost
- $260K
- Opioid Claims
- 672 (5.7% rate)
- Antibiotic Claims
- 181
Patient Demographics
- Average Patient Age
- 80.4 years
- Avg HCC Risk Score
- 2.58
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 32, 65-74: 114, 75-84: 151, 85+: 188
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What BAGDIG BAGHDASSARIAN, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Eliquis
Eliquis
540 claims
- Famotidine
Famotidine
442 claims
- Levothyroxine Sodium
Levothyroxine Sodium
409 claims
- Gabapentin
Gabapentin
380 claims
- Tramadol Hcl
Tramadol Hcl
364 claims
- Atorvastatin Calcium
Atorvastatin Calcium
296 claims
- Potassium Chloride
Potassium Chloride
284 claims
- Metoprolol Tartrate
Metoprolol Tartrate
280 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 540 |
| Famotidine | 442 |
| Levothyroxine Sodium | 409 |
| Gabapentin | 380 |
| Tramadol Hcl | 364 |
| Atorvastatin Calcium | 296 |
| Potassium Chloride | 284 |
| Metoprolol Tartrate | 280 |
| Metoprolol Succinate | 275 |
| Pantoprazole Sodium | 272 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How BAGDIG BAGHDASSARIAN, MD fits within the Internal Medicine Physician landscape nationally.
BAGDIG BAGHDASSARIAN, MD's 11,865 claims are above the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BAGHDASSARIAN.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is BAGDIG BAGHDASSARIAN, MD's specialty? ▼
How much does BAGDIG BAGHDASSARIAN, MD prescribe under Medicare Part D? ▼
What is BAGDIG BAGHDASSARIAN, MD's Medicare quality score? ▼
Where is BAGDIG BAGHDASSARIAN, MD located? ▼
What is BAGDIG BAGHDASSARIAN, MD's NPI number? ▼
Does BAGDIG BAGHDASSARIAN, MD prescribe more brand-name or generic drugs? ▼
Does BAGDIG BAGHDASSARIAN, MD prescribe opioids? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does BAGDIG BAGHDASSARIAN, MD prescribe most often? ▼
Does BAGDIG BAGHDASSARIAN, MD accept Medicare? ▼
How can I verify BAGDIG BAGHDASSARIAN, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology